E22Δ mutation in amyloid β-protein promotes β-sheet transformation, radical production, and synaptotoxicity, but not neurotoxicity

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Irie, Kazuhiro ^a   Suzuki, Takayuki ^a   Murakami, Kazuma ^a   Izuo, Naotaka ^a   Kume, Toshiaki ^a   Akaike, Akinori ^a   Nagata, Tetsu ^b   Nishizaki, Tomoyuki ^b   Tomiyama, Takami ^c   Takuma, Hiroshi ^c   Mori, Hiroshi ^c  

^a KYOTO UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; MUTANT PROTEIN;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; BETA SHEET; COGNITIVE DEFECT; HUMAN; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SYNAPSE;

EID: 79251553420     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/431320     Document Type: Article

References (32)

1. Glenner G. G., Wong C. W., Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochemical and Biophysical Research Communications 1984 120 3 885 890
2. Masters C. L., Simms G., Weinman N. A., Amyloid plaque core protein in Alzheimer disease and Down syndrome Proceedings of the National Academy of Sciences of the United States of America 1985 82 12 4245 4249
3. Haass C., Selkoe D. J., Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid -peptide Nature Reviews Molecular Cell Biology 2007 8 2 101 112
4. Behl C., Davis J. B., Lesley R., Schubert D., Hydrogen peroxide mediates amyloid protein toxicity Cell 1994 77 6 817 827
5. Butterfield D. A., Amyloid -peptide [142]-assosiated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences Current Medicinal Chemistry 2003 10 24 2651 2659
6. Barnham K. J., Masters C. L., Bush A. I., Neurodegenerative diseases and oxidatives stress Nature Reviews Drug Discovery 2004 3 3 205 214
7. Murakami K., Irie K., Ohigashi H., Hara H., Nagao M., Shimizu T., Shirasawa T., Formation and stabilization model of the 42-mer A radical: implications for the long-lasting oxidative stress in Alzheimer's disease Journal of the American Chemical Society 2005 127 43 15168 15174
8. Murakami K., Masuda Y., Shirasawa T., Shimizu T., Irie K., The turn formation at positions 22 and 23 in the 42-mer amyloid peptide: the emerging role in the pathogenesis of Alzheimer's disease Geriatrics and Gerontology International 2010 10 supplement 1 S169 S179
9. Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J., Selkoe D. J., Naturally secreted oligomers of amyloid protein potently inhibit hippocampal long-term potentiation in vivo Nature 2002 416 6880 535 539
10. Roychaudhuri R., Yang M., Hoshi M. M., Teplow D. B., Amyloid β-Protein assembly and Alzheimer disease Journal of Biological Chemistry 2009 284 8 4749 4753
11. Masuda Y., Uemura S., Ohashi R., Nakanishi A., Takegoshi K., Shimizu T., Shirasawa T., Irie K., Identification of physiological and toxic conformations in A 42 aggregates ChemBioChem 2009 10 2 287 295
12. Murakami K., Hara H., Masuda Y., Ohigashi H., Irie K., Distance measurement between Tyr10 and Met35 in amyloid beta by site-directed spin-labeling ESR spectroscopy: implications for the stronger neurotoxicity of A 42 than A 40 Chembiochem 2007 8 18 2308 2314
13. Murakami K., Irie K., Morimoto A., Ohigashi H., Shindo M., Nagao M., Shimizu T., Shirasawa T., Neurotoxicity and physicochemical properties of A mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease Journal of Biological Chemistry 2003 278 46 46179 46187
14. Tomiyama T., Nagata T., Shimada H., Teraoka R., Fukushima A., Kanemitsu H., Takuma H., Kuwano R., Imagawa M., Ataka S., Wada Y., Yoshioka E., Nishizaki T., Watanabe Y., Mori H., A new amyloid variant favoring oligomerization in Alzheimer's-type dementia Annals of Neurology 2008 63 3 377 387
15. Takuma H., Teraoka R., Mori H., Tomiyama T., Amyloid- E22ΔΔ variant induces synaptic alteration in mouse hippocampal slices NeuroReport 2008 19 6 615 619
16. Murakami K., Irie K., Morimoto A., Ohigashi H., Shindo M., Nagao M., Shimizu T., Shirasawa T., Synthesis, aggregation, neurotoxicity, and secondary structure of various A 142 mutants of familial Alzheimer's disease at positions 2123 Biochemical and Biophysical Research Communications 2002 294 1 5 10
17. Naiki H., Gejyo F., Kinetic analysis of amyloid fibril formation Methods in Enzymology 1999 309 305 318
18. Varadarajan S., Kanski J., Aksenova M., Lauderback C., Butterfield D. A., Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A (142) and A (2535) Journal of the American Chemical Society 2001 123 24 5625 5631
19. Murakami K., Uno M., Masuda Y., Shimizu T., Shirasawa T., Irie K., Isomerization and/or racemization at Asp23 of A 42 do not increase its aggregative ability, neurotoxicity, and radical productivity in vitro Biochemical and Biophysical Research Communications 2008 366 3 745 751
20. Shearman M. S., Ragan C. I., Iversen L. L., Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of -amyloid-mediated cell death Proceedings of the National Academy of Sciences of the United States of America 1994 91 4 1470 1474
21. Kume T., Kouchiyama H., Kaneko S., Maeda T., Kaneko S., Akaike A., Shimohama S., Kihara T., Kimura J., Wada K., Koizumi S., BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons Brain Research 1997 756 1-2 200 204
22. Kume T., Nishikawa H., Tomioka H., Katsuki H., Akaike A., Kaneko S., Maeda T., Kihara T., Shimohama S., p75-mediated neuroprotection by NGF against glutamate cytotoxicity in cortical cultures Brain Research 2000 852 2 279 289
23. Nishizaki T., Nomura T., Matuoka T., Kondoh T., Enikolopo G., Sumikawa K., Watabe S., Shiotani T., Yoshii M., The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors Molecular Brain Research 2000 80 1 53 62
24. Chimon S., Ishii Y., Capturing intermediate structures of Alzheimer's -amyloid, A (140), by solid-state NMR spectroscopy Journal of the American Chemical Society 2005 127 39 13472 13473
25. Chimon S., Shaibat M. A., Jones C. R., Calero D. C., Aizezi B., Ishii Y., Evidence of fibril-like β-Sheet structures in a neurotoxic amyloid intermediate of Alzheimer's -amyloid Nature Structural and Molecular Biology 2007 14 12 1157 1164
26. Vargas M. R., Johnson J. A., The Nrf2-ARE cytoprotective pathway in astrocytes Expert reviews in molecular medicine 2009 11 e17
27. Shankar G. M., Li S., Mehta T. H., Garcia-Munoz A., Shepardson N. E., Smith I., Brett F. M., Farrell M. A., Rowan M. J., Lemere C. A., Regan C. M., Walsh D. M., Sabatini B. L., Selkoe D. J., Amyloid- protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nature Medicine 2008 14 8 837 842
28. Chou P. Y., Fasman G. D., -Turns in proteins Journal of Molecular Biology 1977 115 2 135 175
29. Morelli L., Llovera R., Gonzalez S. A., Affranchino J. L., Prelli F., Frangione B., Ghiso J., Castao E. M., Differential degradation of amyloid genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme Journal of Biological Chemistry 2003 278 26 23221 23226
30. Nishitsuji K., Tomiyama T., Ishibashi K., Ito K., Teraoka R., Lambert M. P., Klein W. L., Mori H., The E693 mutation in amyloid precursor protein increases intracellular accumulation of amyloid oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells American Journal of Pathology 2009 174 3 957 969
31. Tomiyama T., Matsuyama S., Iso H., Umeda T., Takuma H., Ohnishi K., Ishibashi K., Teraoka R., Sakama N., Yamashita T., Nishitsuji K., Ito K., Shimada H., Lambert M. P., Klein W. L., Mori H., A mouse model of amyloid oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo Journal of Neuroscience 2010 30 14 4845 4856
32. Murakami K., Horikoshi-Sakuraba Y., Murata N., Monoclonal antibody against the turn of the 42-residue amyloid beta protein at positions 22 and 23 ACS Chemical Neuroscience 2010 1 11 747 756